Are animal models predictive for humans?
Open accessThe DOI matches its Crossref record; 77 of the 79 references it cites were found in a registry or an index.
Abstract
It is one of the central aims of the philosophy of science to elucidate the meanings of scientific terms and also to think critically about their application. The focus of this essay is the scientific term predict and whether there is credible evidence that animal models, especially in toxicology and pathophysiology, can be used to predict human outcomes. Whether animals can be used to predict human response to drugs and other chemicals is apparently a contentious issue. However, when one empirically analyzes animal models using scientific tools they fall far short of being able to predict human responses. This is not surprising considering what we have learned from fields such evolutionary and developmental biology, gene regulation and expression, epigenetics, complexity theory, and comparative genomics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“first because referencing practices are suboptimal (compare e.g. the data and figures from [5, 72, 73, 77].”
From Animal to human translation: a systematic scoping review of reported concordance rates (2019) · cites this paper as [5]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Traditional two-dimensional cell cultures and in vivo animal studies fail to fully recapitulate human cardiac physiology, highlighting the urgent need for more relevant human-based models.”
From Mini-hearts for disease modeling and drug testing – process optimization versus biological functionality (2026) · cites this paper as Shanks et al., 2009
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Regulatory and research leaders are increasingly taking notice of the issue.”
From Limitations of Animal Studies for Predicting Toxicity in Clinical Trials (2019) · cites this paper as [62]
The cited source says what the claim attributes to it.
In the citing paper
“Even if the design and conduct of an animal experiment are sound and standardized, the translation of its results to the clinic may fail because of disparities between the animal experimental model and the human condition.21”
From The Flaws and Human Harms of Animal Experimentation (2015) · cites this paper as [21]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
IARC Monographs on the Evaluation of Carcinogenic Risks to Humans
Zuckerman, A. J. (1995) · Journal of Clinical Pathology · doi:10.1136/jcp.48.7.691-a · Cited by 8,728
Epigenetic differences arise during the lifetime of monozygotic twins
Fraga, M. F., Ballestar, E., Paz, M. F., Ropero, S., Setien, F., Ballestar, M. L., Heine-Suñer, D., Cigudosa, J. C., Urioste, M., Benitez, J., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500398102 · Cited by 3,602 · cited 1×
“The response of different humans to the same drug or disease is a well-known example of this phenomenon [7-13].”
Bleyl, D. W. R. (1989) · Food / Nahrung · doi:10.1002/food.19890330516 · Cited by 2,305
Concordance of the toxicity of pharmaceuticals in humans and in animals
Olson, H., Betton, G., Robinson, D., Thomas, K., Monro, A., Kolaja, G., Lilly, P., Sanders, J., Sipes, G., Bracken, W., et al. (2000) · Regulatory Toxicology and Pharmacology · doi:10.1006/rtph.2000.1399 · Cited by 2,050 · cited 2×
“The Olson study [78] purports (and has certainly been cited in this regard) to provide evidence of the vast predictive utility of animal models in assessing human toxicity.”
IARC monographs on the evaluation of carcinogenic risks to humans
(1989) · Food and Chemical Toxicology · doi:10.1016/0278-6915(89)90053-7 · Cited by 1,447
Casarett and Doull's toxicology
ed, T. (2015) · Cited by 1,127
Modelling the molecular circuitry of cancer
Hahn, W. C., & Weinberg, R. A. (2002) · Nature Reviews Cancer · doi:10.1038/nrc795 · Cited by 944 · cited 1×
“It also appears that fewer genetic, epigenetic, or gene expression events are needed to induce cancer in rodents than are needed to induce cancer in humans [72-74].”
Bruder, C. E. G., Piotrowski, A., Gijsbers, A. A. C. J., Andersson, R., Erickson, S., Diaz de Ståhl, T., Menzel, U., Sandgren, J., von Tell, D., Poplawski, A., et al. (2008) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2007.12.011 · Cited by 599 · cited 1×
“The response of different humans to the same drug or disease is a wellknown example of this phenomenon [7-13].”
Failing the Public Health — Rofecoxib, Merck, and the FDA
Topol, E. J. (2004) · New England Journal of Medicine · doi:10.1056/nejmp048286 · Cited by 599 · cited 1×
“Figures vary, and are controversial, but it now appears that apparently less than 1% of people who took rofecoxib experienced a heart attack or stroke as a result, yet it was also withdrawn [35].”
Comparative biology of mouse versus human cells: modelling human cancer in mice
Rangarajan, A., & Weinberg, R. A. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1235 · Cited by 567 · cited 1×
“It also appears that fewer genetic, epigenetic, or gene expression events are needed to induce cancer in rodents than are needed to induce cancer in humans [72-74].”
Research works printed but not linked: 14
- Greek R Greek J Specious Science 2002 New York: Continuum Int
- Salmon W Curd M, Cover J, Norton Rational Prediction Philosophy of Science 1998 433 444
- Uehling M Microdoses of Excitement over AMS, 'Phase 0' Trials Bio-IT World 2006 2006
- Greek J Greek R What Will We Do if We Don't Experiment on Animals. Continuum 2004
- Sankar U The Delicate Toxicity Balance in Drug Discovery The Scientist 2005 19 32
- Tomatis L Wilbourn L Iversen Evaluation of carcinogenic risk to humans: the experience of IARC New Frontiers in Cancer Causation 2003 Washington, DC: Taylor and Francis 371 387
- Caldwell J Jakoby W Comparative Aspects of Detoxification in Mammals Enzymatic Basis of Detoxification 1980 1 New York: Academic Press
- Clemmensen J Hjalgrim-Jensen S Alex Pub On the absence of carcinogenicity to man of phenobarbital Human Epidemiology and Animal Laboratory Correlations in Chemical Carcinogenesis 1980 Coulston F, Shubick S 251 265
- Clayson D Coulston F, Shubick P The carcinogenic action of drugs in man and animals Human Epidemiology and Animal Laboratory Correlations in Chemical Carcinogenesis 1980 Ablex Pub 185 195
- Anisimov V Molecular and Physiological Mechanisms of Aging 2003 St Petersburg: Nauka
- Kolata G 2 Top Diet Drugs Are Recalled Amid Reports of Heart Defects New York Times. New York 1997
- Shanks N Greek R Nobis N Greek J Animals and Medicine: Do Animal Experiments Predict Human Response? Skeptic 2007 13 44 51
- Conn P Parker J Letter. Animal research wars Skeptic 2007 13 18 19
- Morange M A successful form for reductionism The Biochemist 2001 23 37 39
Cited by
Items 501–600 of 778
Onakpoya, I., Heneghan, C. J., & Aronson, J. K. (2017) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.4256 · Cited by 5
“The value of using animal research to predict harms of medicinal interventions in humans is highly debatable, because of challenges on how to extrapolate the results.(20,21) This is especially concerning when the results of formal human studies on harms are at variance with the findings in animals.”
BackgroundTime to take stock of Indian regulatory guidelines regarding drug use in pregnancy and lactation
Patil, A., & Arora, A. (2019) · Indian Journal of Pharmacology · doi:10.4103/ijp.ijp_647_18 · Cited by 5
“Involvement of all stakeholders such as the pharmaceutical industry and regulatory and healthcare providers is necessary to build a platform on designing advocacy norms and precautions for Indian pregnant and lactating population.[3] Since most of the current drug discoveries happening are carrying this PLLR informati…”
Roelcke, V. (2022) · Science in Context · doi:10.1017/s0269889723000170 · Cited by 5
“9 Some of the epistemological fallacies involved in animal model research are discussed in Shanks et al. 2009.”
BackgroundDearden, J. C., Hewitt, M., Bresnen, G. M., & Cn, G. (2017) · SAR and QSAR in environmental research · doi:10.1080/1062936x.2017.1351391 · Cited by 5
Medical Devices Biological Safety Assessment: Towards Animal-free Testing
Sachot, N., & Vitale, A. (2019) · Derecho Animal Forum of Animal Law Studies · doi:10.5565/rev/da.392 · Cited by 5
Safe-in-Man Broad Spectrum Antiviral Agents
Yao, R., Ianevski, A., & Kainov, D. E. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-981-16-0267-2_12 · Cited by 5
Lassarén, P., Conley, G. M., Boucher, M. L., Conley, A. N., Morriss, N. J., Qiu, J., Mannix, R., & Thelin, E. P. (2023) · Journal of Neurotrauma · doi:10.1089/neu.2022.0486 · Cited by 5
“Commonly, animal studies measure a set of behavioral outcomes that are considered to be analogous to those used in clinical settings, often deployed to quantify a treatment effect.(5) However, because of the complex recovery of the injured brain and difficulty in scaling animal models to human TBI, the outcomes measur…”
BackgroundAbud, A. P. R., Kuligovski, C., Corrêa, N. C. R., de Moraes, E. C. P., Caruso, R. R. B., Schuck, D. C., Brohem, C. A., Dallagiovanna, B., & de Aguiar, A. M. (2019) · Toxicology Letters · doi:10.1016/j.toxlet.2019.04.009 · Cited by 5
Utilization of a mouse/human chimeric model for long term metabolic testing of human skin
Quantin, P., Ghazi, K., Pereira, U., Smith, A., Degardin, L., Vigneron, P., Ficheux, H., Garlick, J. A., Rapetti, L., & Egles, C. (2019) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2019.106663 · Cited by 5
Krakowian, D., Gądarowska, D., Daniel-Wójcik, A., & Mrzyk, I. (2022) · Toxicology in Vitro · doi:10.1016/j.tiv.2022.105343 · Cited by 5
A novel pipeline for computerized mouse spermatogenesis staging
Lu, H., Zang, M., Marini, G. P. L., Wang, X., Jiao, Y., Ao, N., Ong, K., Huo, X., Li, L., Xu, E. Y., et al. (2022) · Bioinformatics · doi:10.1093/bioinformatics/btac677 · Cited by 5
Varesano, S., Zocchi, M. R., & Poggi, A. D. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01343 · Cited by 5
State of Research on Tissue Engineering with 3D Printing for Breast Reconstruction
Velasquez, G. D. D. S., Tanas, Y., Taraballi, F., Herzog, T., & Spiegel, A. J. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14196737 · Cited by 4
“Ethically, exposing patients to potential risks without comprehensive prior testing challenges the medical principle of “do no harm”(82, 83).”
Las Tres Ces como ampliación de las Tres Erres para una praxis ética en la investigación biomédica
Ballesteros, E. E. T., & Cantón, B. V. (2021) · Revista de Bioética y Derecho · doi:10.1344/rbd2021.51.32556 · Cited by 4
Potential Uses of Adhatoda Vasica in Orthodontics
Subramanian, M., Selvaraj, K. K., Jagannathan, R., Rajendran, S., Rajendran, D., & Balaji, T. M. (2023) · Journal of Pharmacy And Bioallied Sciences · doi:10.4103/jpbs.jpbs_74_23 · Cited by 4
Innovative Strategies in Regenerative Medicine: Bridging Science and Clinical Practice
Bhutambare, V., Kamble, C., Khilari, S., Bhalekar, D., Gawari, P., & Kanase, A. (2024) · International Journal of Advanced Research in Science Communication and Technology · doi:10.48175/ijarsct-22230 · Cited by 4
Pérez, M., Rojo‐Solís, C., & Encinas, M. T. (2009) · Revista Complutense de Ciencias Veterinarias · doi:10.5209/rccv.23591 · Cited by 4
“En el diseño de los mismos las claves son: la elección de la especie animal que más se adapte al estudio y la viabilidad de la extrapolación de los resultados desde la especie modelo a la especie en que se vayan a aplicar los resultados obtenidos, incluyendo el hombre (Shanks et al., 2009).”
BackgroundDrug Discovery and Preclinical Development
Barrett, J. S. (2022) · Wiley eBooks · doi:10.1002/9781119913276.ch6 · Cited by 4
From shape to function—bioprinting technologies for tissue engineered grafts to meet clinical needs
Murugan, D., Mishra, P., Bhat, S. N., Pandey, V., Mallick, S. P., Guruprasad, K. P., Srivastava, P., & Singh, B. N. (2023) · International Journal of Polymeric Materials · doi:10.1080/00914037.2023.2201947 · Cited by 4
“These constructs may provide a more accurate representation of drug action in humans than animal testing by creating tissues that better mimic the native living environment [6] .”
BackgroundPreclinical Research: A Rise or Dawn
Manjunath, S. R. (2018) · Pharmacy & Pharmacology International Journal · doi:10.15406/ppij.2018.06.00147 · Cited by 4
Falland-Cheung, L., Waddell, J. N., Li, K. C., Tong, D., & Brunton, P. A. (2018) · Journal of Concussion · doi:10.1177/2059700218777829 · Cited by 4
“Head injury models using animals have been previously used; however, their main disadvantage is that the head anatomy of animals is incomparable to humans.(2) Obtaining in vivo data from living animal or human cranial impact studies is clearly unacceptable.”
BackgroundImpact of dosing schedule in animal experiments on compound progression decisions
Chen, C. (2018) · Drug Discovery Today · doi:10.1016/j.drudis.2018.11.006 · Cited by 4
Migration Assay for Leukemic Cells in a 3D Matrix Toward a Chemoattractant
Zippel, S., Raić, A., & Lee‐Thedieck, C. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9574-5_8 · Cited by 4
Read-across approaches: current applications and regulatory acceptance in Korea, Japan, and China
Lee, B., Lee, S. H., Yamada, T., Park, S., Wang, Y., Kim, K., & Kwon, S. (2021) · Journal of Toxicology and Environmental Health · doi:10.1080/15287394.2021.1992323 · Cited by 4
The Dialectical Primatologist: The Past, Present and Future of Life in the Hominoid Niche
Malone, N. (2021) · Routledge eBooks · doi:10.4324/9780367211349 · Cited by 4
Could a phase model help to improve translational animal research?
Mayer, B., Tuckermann, J. P., & Muche, R. (2022) · Animal Models and Experimental Medicine · doi:10.1002/ame2.12284 · Cited by 4
Validity Drifts in Psychiatric Research
Michel, M. (2024) · The British Journal for the Philosophy of Science · doi:10.1086/730534 · Cited by 4
Biodefense Research and the U.S. Regulatory Structure: Whither Nonhuman Primate Moral Standing?
Walker, R. L., & King, N. M. P. (2011) · Kennedy Institute of Ethics journal · doi:10.1353/ken.2011.0012 · Cited by 4
Investigación preclínica en las ciencias biomédicas
Navarro, D. I. M. (2015) · Revista Cubana de Estomatología · Cited by 4
Retinal Organoids: An Emerging Technology for Retinal Disease Research and Therapy
Aparicio, J. G., Shayler, D. W., & Cobrinik, D. E. (2017) · Springer eBooks · doi:10.1007/978-3-319-49479-1_10 · Cited by 4
Flavonoids and Visual Function
Field, D. T., Bell, L., Mount, S. W., Williams, C. M., & Butler, L. T. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-401717-7.00041-1 · Cited by 4
A suggestion for evolution of Canada’s health regulatory system
White, J., & Reid, G. (2018) · FACETS · doi:10.1139/facets-2017-0049 · Cited by 4
Assessment of drug-loaded nanoparticles in a 3D in vitro brain tumour model
Ivanov, D. P. (2015) · Nottingham ePrints (University of Nottingham) · Cited by 4
McGlacken, R. (2021) · Cited by 4
Yu, X., Li, H., Ou, H., Ma, L., Yu, K., Li, G., Ming, T., Wang, J., Zhang, M., & Kang, F. (2026) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c03763 · Cited by 3
Greek, R. (2014) · Biological Systems Open Access · doi:10.4172/2329-6577.1000124 · Cited by 3
“These advances are summarized as TSMT.”
BackgroundMethodInfluentialSelf-citationBiological Activity of Metal Oxide Nanoparticles
Himly, M., Geppert, M., & Duschl, A. (2021) · Wiley eBooks · doi:10.1002/9781119436782.ch21 · Cited by 3
Nayak, S., Sondkar, A., Vinchurkar, G., Shirsath, S., Shintre, S., & Vaidhun, B. (2024) · Journal of Exploratory Research in Pharmacology · doi:10.14218/jerp.2023.00006s · Cited by 3
Stem Cell Predictive Hemotoxicology
Harper, H., & Ivan, N. (2013) · InTech eBooks · doi:10.5772/54430 · Cited by 3
“It is not uncommon for unexpected results or toxicity to rear its head during animal studies be‐ cause of the lack of predictive information obtained during previous screening and testing [13].”
BackgroundHuman Stem/Progenitor Cell-Based Assays for Neurodevelopmental Toxicity Testing
Fritsche, E. (2014) · Methods in pharmacology and toxicology · doi:10.1007/978-1-4939-0521-8_16 · Cited by 4
Rana, P., Khan, S., Arat, S., Potter, D., & Khan, N. (2022) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.2c00243 · Cited by 3
Alzheimer’s Disease Drugs in Clinical Trials
Sheerin, M., & Adejare, A. A. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802810-0.00013-1 · Cited by 3
Pre-clinical disease models in drug toxicity evaluation
Foster, M. L. (2017) · Current Opinion in Toxicology · doi:10.1016/j.cotox.2017.06.001 · Cited by 3
How the Suffering of Nonhuman Animals and Humans in Animal Research is Interconnected
Kranke, N. (2020) · Journal of Animal Ethics · doi:10.5406/janimalethics.10.1.0041 · Cited by 3
“…animals are a poor model for humans and cannot reliably predict the safety or effectiveness of medicines or other chemicals,” which puts patients at risk and causes researchers to wrongly discard potentially effective treatments (Archibald, 2018, p. 3; see also Akhtar, 2015; Shanks et al., 2009).”
Radiation induced cardiovascular disease: An odyssey of bedside-bench-bedside approach
Rikhi, R. R., Samra, G. S., Arustamyan, M., Patel, J., Zhou, L., Bungo, B., & Moudgil, R. (2020) · Life Sciences in Space Research · doi:10.1016/j.lssr.2020.07.005 · Cited by 3
Hidden in Plain Sight: The History, Science, and Engineering of Microfluidic Technology
Folch, A. (2022) · The MIT Press eBooks · doi:10.7551/mitpress/14236.001.0001 · Cited by 3
Samrani, L. M. M., Dumont, F., Hallmark, N., Bars, R., Tinwell, H., Pallardy, M. J., & Piersma, A. H. (2023) · Reproductive Toxicology · doi:10.1016/j.reprotox.2023.108404 · Cited by 3
James, B. C., Cox, A. J., & Lewohl, J. M. (2024) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.15340 · Cited by 3
Härtung, T. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-409547-2.12378-9 · Cited by 3
Glatard, A., Berges, A., Sahota, T., Ambery, C. L., Osborne, J., Smith, R., Hénin, É., & Chen, C. (2015) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2015.07.022 · Cited by 3
Predictive Toxicology: Latest Scientific Developments and Their Application in Safety Assessment
Armstrong, D., Li, S., Frieauff, W., Martus, H. ‐., Reilly, J., Mikhailov, D., Whitebread, S., & Urbán, L. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-409547-2.12367-4 · Cited by 3
Bio-3D Printed Organs as Drug Testing Tools
Arai, K., & Nakayama, K. (2021) · Springer eBooks · doi:10.1007/978-3-030-58688-1_12 · Cited by 3
Commentary: Basic Research in HIV Vaccinology Is Hampered by Reductionist Thinking
Regenmortel, M. H. V. V. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00266 · Cited by 3
“It is widely accepted today that a vaccine response in NHPs (whether positive or negative) is not at all predictive of what is likely to happen in humans (15, 16).”
BackgroundGreek, J., & Shanks, N. (2009) · Journal of the American Veterinary Medical Association · doi:10.2460/javma.235.4.363 · Cited by 3
Self-citationZhang, S., Yang, R., Yin, N., & Faiola, F. (2025) · Environment & Health · doi:10.1021/envhealth.4c00270 · Cited by 2
iDILI-MT: identifying drug-induced liver injury compounds with a multi-head Transformer
Zheng, W., & Lai, F. (2025) · PeerJ Computer Science · doi:10.7717/peerj-cs.2973 · Cited by 2
“This translation gap was fairly discussed in a comprehensive analysis by Shanks, Greek & Greek (2009) .”
Relinquishing experimental control to improve translation
Wallis, J. M. (2025) · Synthese · doi:10.1007/s11229-025-05219-9 · Cited by 2
“…that little can be learned from model organisms when it comes to translation because such animals are more properly understood as heuristic tools, not as bases for extrapolation or prediction (Greek & Menache, 2013; Knight, 2019; LaFollette & Shanks, 1995; Libby, 2015; Shanks et al., 2009).”
Bao, Q., Clarke, J. G., Curran, D. W., Romić, M. D., Goyal, N., Heimbach, T., Jain, K. M. H., Pawar, P., Ragoonanan, V., Saha, P., et al. (2026) · Journal of Controlled Release · doi:10.1016/j.jconrel.2026.114959 · Cited by 2
Cracking the shield: oncolytic viruses versus the tumor-immune fortress
El-Derby, A. M., Salem, N. T., Hesham, N., & Salem, T. Z. (2026) · Cancer Cell International · doi:10.1186/s12935-026-04331-1 · Cited by 2
“Organoids grow rapidly and avoid the inter-species interaction issues inherent in xenograft models [196], and therefore can be considered a highly relevant model for cancer research [197, 197].”
Merighi, F., Vincentiis, S. D., Onorati, M., & Raffa, V. (2024) · Journal of Visualized Experiments · doi:10.3791/66704 · Cited by 2
Kamath, V., Maria, S., Satelur, K. P., & Rajkumar, K. (2015) · Journal of Orofacial Sciences · doi:10.4103/0975-8844.157364 · Cited by 2
Normative dilemmas in Sweden's ethical review policy for animal experiments
Svärd, P.-A. (2017) · The Global Journal of Animal Law · Cited by 2
Nanomaterials in Medical Devices: Regulations' Review and Future Perspectives
Jagiełło, K., Sosnowska, A., Mikołajczyk, A., & Puzyn, T. (2017) · Journal of Nanotoxicology and Nanomedicine · doi:10.4018/jnn.2017070101 · Cited by 2
Ma, J., Yin, B., Shi, J., Lin, Y., Duan, S., Shi, B., & Jia, Z. (2019) · Europe PMC (PubMed Central) · Cited by 2
Gundersen, J. K., Menassa, D. A., Wood, T. R., Walløe, L., & Thoresen, M. (2021) · Developmental Neuroscience · doi:10.1159/000521438 · Cited by 2
Girard, W.-P., Bertrand‐Grenier, A., & Drolet, M.-J. (2022) · Canadian Journal of Bioethics · doi:10.7202/1089790ar · Cited by 2
“For instance, because of the important differences between animals and human beings, only a small proportion of animal experiments lead to satisfactory results in order to move forward with a clinical phase, which is a major transferability problem (20-22).”
BackgroundHuman Toxicity of Nano‐ and Microplastics
Cruz‐Salas, A. A., Velasco-Pérez, M., Bobadilla, A. L. T., Vázquez‐Morillas, A., & Valdemar, R. M. E. (2024) · Wiley eBooks · doi:10.1002/9781394238163.ch15 · Cited by 2
Comparing liver RNA-seq analysis of human, rhesus monkey, mouse and rat
Chen, A., Ji, C., Li, C., & Zhang, S. (2024) · Gene Reports · doi:10.1016/j.genrep.2024.102075 · Cited by 2
Horiuchi, S., Koda, N., Ikeda, Y., Tanaka, Y., Masuo, Y., Kato, Y., & Yamazaki, D. (2024) · PLoS ONE · doi:10.1371/journal.pone.0315997 · Cited by 2
Qi, Y. X., Liu, Y., Li, X., Xu, J., & Zhang, Q. (2025) · CrystEngComm · doi:10.1039/d4ce01171f · Cited by 2
Advancing knowledge requires both clinical and basic research
Vohra, S., & Boon, H. S. (2015) · Focus on Alternative and Complementary Therapies · doi:10.1111/fct.12160 · Cited by 2
Nagayama, T., Nishida, M., Hizue, M., Ogino, Y., & Fujiyoshi, M. (2015) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.12494 · Cited by 2
Underdetermined Interests: Scientific ‘Goods’ and Animal Welfare
Degeling, C., & Johnson, J. (2009) · The American Journal of Bioethics · doi:10.1080/15265160903234177 · Cited by 2
“Even if the issues that surround the extrapolation of animal-based scientific knowledge to humans remain unresolved, and therefore open to dispute, it is possible that within this extended framework ethically and epistemically ‘good’ science can be nudged even closer to becoming a conjoined enterprise ( Shanks et al.…”
BackgroundFrom Mice to Men: Translation from Bench to Bedside
Martić-Kehl, M. I., & Schubiger, P. A. (2016) · John Wiley & Sons, Inc. eBooks · doi:10.1002/9781118865064.ch13 · Cited by 2
Indraganti, P. K., Namita, I., & Khanna, A. (2019) · Biomedical Research and Clinical Practice · doi:10.15761/brcp.1000194 · Cited by 2
“In fact, the translatability of the data generated based on the experimental animals like rodents, non-human primates are an area of intense debate [78].”
BackgroundMicrofluidic modeling of the glomerulus and tubular appartus
Mahler, G. J., & Zhang, S. Y. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-823318-4.00021-4 · Cited by 2
HUMANS, ANIMALS, AND PETRI DISHES: BIOMEDICAL MODELING BETWEEN EXPERIMENTATION AND REPRESENTATION
Germain, P. (2014) · Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) · doi:10.13130/germain-pierre-luc_phd2014-03-25 · Cited by 2
Plasma levels of serum amyloid A1 and mortality after exposure to high-dose radiation
Klokov, D. Y. (2020) · Annals of Translational Medicine · doi:10.21037/atm.2020.03.172 · Cited by 2
“Can these results obtained in mice be extrapolated to humans? Inability to reproduce effects observed in preclinical studies in humans is a well appreciated issue in translational biomedical research (22-24).”
BackgroundDevelopment and Application of 2D and 3D In vitro Models for Human Brain Development
Heidman-Sivitilli, A. (2019) · TSpace (University of Toronto) · Cited by 2
(2018) · Wiley eBooks · doi:10.1002/9781118280249.refs · Cited by 2
Pazera, P., Fudalej, P. S., & Katsaros, C. (2012) · American Journal of Orthodontics and Dentofacial Orthopedics · doi:10.1016/j.ajodo.2012.11.006 · Cited by 2
Gigante, S., Raghavan, V. G., Robinson, A. M., Barton, R. A., Rahman, A. H., Wulsin, D., Banchereau, J., Solomon, N., Voloch, L. F., & Theis, F. J. (2022) · arXiv (Cornell University) · doi:10.48550/arxiv.2205.07110 · Cited by 2
International biophysics collaboration meeting : book of abstracts
Durante, M., Pleskac, R., & Graeff, C. (2019) · GSI Repository (German Federal Government) · doi:10.15120/gsi-2019-00596 · Cited by 2
Therapeutic applications of three-dimensional organoid models in lung cancer
Yeo, C. D., Yun, Y.-P., Ahn, D. H., Hwang, Y., Yang, S. H., Won, H., Cho, H. J., Park, C. K., Kim, S. J., & Park, J. Y. (2021) · Organoid · doi:10.51335/organoid.2021.1.e6 · Cited by 1
“Although culture models from animal lungs have been developed [78], culture from primary human cells can be hampered by logistical challenges.”
Studies of Reactive Metabolites using Genotoxicity Arrays and Enzyme/ DNA Biocolloids – 2021
Rusling, J. F., & Hvastkovs, E. G. (2022) · Wiley eBooks · doi:10.1002/9781119851042.ch12 · Cited by 1
Nonclinical safety assessment of vaccines: Up to date applications
Yavaşoğlu, N. Ü. K. (2024) · Ege Tıp Dergisi · doi:10.19161/etd.1542896 · Cited by 1
“Despite this, animal models in toxicology and pathophysiology can be used to predict human outcomes (26).”
Längst, E., & Prudent, M. (2025) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2025.102935 · Cited by 1
Wang, W., Ren, M., & Lu, D. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1682105 · Cited by 1
Jacek, T., Szkopek, D., Wychowański, P., Donaldson, J., Zaworski, K., Strutyński, M., Kirko, S. N., Prykhodko, O., Fedkiv, O., Pierzynowski, S. G., et al. (2026) · Frontiers in Physiology · doi:10.3389/fphys.2025.1692403 · Cited by 1
“This has been listed as one reason for caution in extrapolating results to people, who demonstrate higher genetic variety (Penniston et al., 2017; Shanks et al., 2009).”
Rosalem, G. S., de Assis, D. R. R., Torres, L. A. G., Casas, E. B. D. L., Rodrigues, W. N., Gonçalves, R. S., Rabelo, R. A. N., Ruiz, J. C., & Carvalho, M. G. R. (2026) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2026.1766296 · Cited by 2
“On the other hand, animal models frequently fail to accurately replicate human pathophysiology, hindering the extrapolation of experimental results and predictions (Shanks et al., 2009).”
Sidhic, J., Singh, M. T., K., S. M. C., Prasad, A., Sarbadhikary, P., Krishnamurthy, P. T., Sulaiman, C., Narayanankutty, A., Abrahamse, H., George, S., et al. (2026) · Chemistry & Biodiversity · doi:10.1002/cbdv.71460 · Cited by 1
“Researchers can explore the mechanisms of action, metabolism, and potential adverse effects of bioactive substances using mouse models, ultimately aiding in the development of innovative plant-based medicines [14, 15].”
Towards a More Robust Approach to Selecting and Prosecuting Promising Targets and Compounds
Graeme, R. (2009) · Future Medicinal Chemistry · doi:10.4155/fmc.09.135 · Cited by 1
Mining a Nanoparticle Dataset, Compiled Within the MODENA-COST Action
Miert, S. V., Creylman, J., & Verheyen, G. R. (2018) · International Journal of Quantitative Structure-Property Relationships · doi:10.4018/ijqspr.2019010101 · Cited by 1
Animal Models in Science and Research
Greek, R. (2019) · Wiley eBooks · doi:10.1002/9781118907283.ch29 · Cited by 1
Self-citationA tale of many models. Which one creates the best of times?
Sharples, S. A., & Whelan, P. J. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-816477-8.00016-8 · Cited by 1
Computational modeling of the pharmacokinetics and pharmacodynamics of selected xenobiotics
Zurlinden, T. J., Reisfeld, B., Hays, S., Shipman, P., & Munsky, B. (2016) · Digital Collections of Colorado (Colorado State University) · doi:10.25675/3.023356 · Cited by 1
Quality of Reporting in Human Aortic Tissue Research — A Systematic Review
Chim, Y.-H., Caamaño‐Gutiérrez, E., Birla, R. P., Madine, J., Field, M., Akhtar, R., & Davies, H. A. (2019) · Artery Research · doi:10.2991/artres.k.191106.003 · Cited by 1
“Here we propose five simple recommendations for the reporting of human tissue with the primary aim of improving reproducibility and transparency in the sector, avoiding bias and maximising output. animal studies to human trials, resulting in a high drop-out rate at failed clinical trials [9,10].”
Immunotoxicity Testing – In Vitro Cell Culture Models
Rothen‐Rutishauser, B., Drašler, B., & Petri‐Fink, A. (2020) · Molecular and integrative toxicology · doi:10.1007/978-3-030-33962-3_11 · Cited by 1
When the How Outweighs the What: the Pivotal Importance of Context
Lyman, C. A., Anderson, C., Morris, M., Nandal, U. K., Martindale, M. J., Clement, M., & Broderick, G. (2019) · IEEE International Conference on Bioinformatics and Biomedicine (BIBM) · doi:10.1109/bibm47256.2019.8983294 · Cited by 1
Grabowski, T., Burmańczuk, A., & Miążek, A. (2020) · Polish Journal of Veterinary Sciences · doi:10.24425/pjvs.2020.132748 · Cited by 1
“One of the problems of optimizing animal models is the individual-between variability they generate (Shanks et al. 2009 , Bittner et al. 2012 ).”
Background
Metadata
- Authors
- Shanks, N., Greek, R., & Greek, J.
- Affiliations
- Wichita State University (US)
- Corresponding author
- Greek, Ray
- Venue
- Philosophy, Ethics, and Humanities in Medicine
- Published
- 2009-01-15
- Volume
- 4
- Issue
- 1
- Pages
- 2-2
- ISSN
- 1747-5341 (ISSN-L)
- PMC
- PMC2642860
- OpenAlex
- W2030932194
- Cited by
- 677
- References
- 79
- Citations by year
- 2026: 18 · 2025: 38 · 2024: 53 · 2023: 43 · 2022: 66 · 2021: 69 · 2020: 69 · 2019: 64 · 2018: 67 · 2017: 47 · 2016: 37 · 2015: 35 · 2014: 19 · 2013: 21 · 2012: 13
- FWCI
- 2.28
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- Philosophy Ethics and Humanities in Medicine (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- WBI Studies Repository (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Topics
- Health Sciences › Veterinary › Small Animals › Animal testing and alternatives
- Social Sciences › Arts and Humanities › History and Philosophy of Science › Philosophy of Biology and Scientific Explanation
- Health Sciences › Nursing › Issues, ethics and legal aspects › Biomedical Ethics and Regulation
- Keywords
- animal models, predictive validity, animal-to-human extrapolation, toxicology, pathophysiology, drug response prediction, scientific terminology, epigenetics, comparative genomics, complexity theory, evolutionary biology, developmental biology, gene expression regulation
- MeSH terms
- Animals, Forecasting, Humans, Models, Animal, Animal Experimentation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.